ALPX, an EMBL spin-off and French CRO, delivers fully transparent structural biology services to biotech and pharma companies. We provide accelerated and high-quality structural insights that enable our partners to focus on optimizing their small molecule or biologic projects into promising lead candidates. With our automated protein crystallography and cryo-EM platforms, we offer a one-stop-shop solution for all structural biology needs. To know more
